ELTP .282 Positive Phase 3 data just out - Going to RUN on NEWS of FDA NDA FILING $$$$$ http://ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=79416&GoTopage=1&Category=2163&BzID=2258&t=1948&G=939 Elite intends to submit a New Drug Application to the U.S. Food and Drug Administration for abuse-deterrent ELI-200 by year-end.